Deutsche Bank analyst Emmanuel Papadakis upgraded Roche (RHHBY) to Hold from Sell with a price target of CHF 265, up from CHF 235. The firm is less cautious on the shares following fenebrutinib’s results in multiple sclerosis.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RHHBY: